Thomas (Tom) Spurling Acquires 78,273 Shares of Nova Eye Medical (ASX:EYE) Stock

Nova Eye Medical Limited (ASX:EYE) insider Thomas (Tom) Spurling bought 78,273 shares of Nova Eye Medical stock in a transaction that occurred on Monday, September 1st. The stock was purchased at an average cost of A$0.15 per share, with a total value of A$11,740.95.

Nova Eye Medical Price Performance

The stock has a market capitalization of $34.22 million, a P/E ratio of -3.21 and a beta of 0.96. The company has a quick ratio of 3.05, a current ratio of 2.60 and a debt-to-equity ratio of 15.70.

Nova Eye Medical Company Profile

Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. It offers iTrack, a glaucoma surgical device to reduce intraocular pressure in adult patients with open-angle glaucoma; iTrack Advance, a canaloplasty microcatheter; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration.